HFM
JAZZ icon

Harvest Fund Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Harvest Fund Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5
Closed -$1K – 689
2025
Q1 		$1K Buy
+5
New +$652 ﹤0.01% 647
2023
Q1 		– Sell
-175
Closed -$28K – 782
2022
Q4 		$28K Sell
175
-183
-51% -$26.8K 0.01% 560
2022
Q3 		$48K Buy
+358
New +$54.4K 0.01% 424
2018
Q4 		– Sell
-325
Closed -$55K – 389
2018
Q3 		$55K Buy
+325
New +$55.9K 0.01% 349

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Harvest Fund Management's JAZZ Position: Q2 2025 in Review

Harvest Fund Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 5 shares — an estimated $1K sold.

Harvest Fund Management first reported a position in JAZZ in Q3 2018 and held it in 4 quarters. The position peaked at $55K in Q3 2018. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Harvest Fund Management reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Harvest Fund Management sold 5 Jazz Pharmaceuticals shares in Q2 2025, an estimated $1K.
  • Harvest Fund Management first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Harvest Fund Management's Jazz Pharmaceuticals position peaked at $55K in Q3 2018.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Harvest Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.